BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 29, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Corcept nears enrollment completion in phase III Corlux trial
June 29, 2010
CHMP recommends approval of Shire's VPRIV for type 1 GD
June 29, 2010
Interim phase II data reported on ENB-0040 in childhood hypophosphatasia
June 29, 2010
Pooled phase III data show efficacy of tesamorelin in HIV-related lipodystrophy
June 29, 2010
Sanofi-aventis and Metabolex enter into licensing agreement for novel antidiabetic
June 28, 2010
FDA advisory committee meeting scheduled to review Contrave NDA
June 28, 2010
Versartis commences phase Ia trial of VRS-859 in type 2 diabetes
June 28, 2010
GSK claims calcium-sensing CaS receptor ligands
June 28, 2010
RAD-1901 is efficacious in phase IIa trial in postmenopausal women
June 28, 2010
Novo Nordisk restarts phase III development of liraglutide for obesity
June 25, 2010
Previous
1
2
…
691
692
693
694
695
696
697
698
699
…
1801
1802
Next
RSS